Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Bionpharma – Recall of atovaquone oral suspension
September 17, 2024 - Bionpharma announced a consumer level recall of one lot of atovaquone oral suspension because the lot contained Cohnella bacteria.
